Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naltrexone eye drops for neuropathic corneal pain after cataract surgery
IRCT20251016067651N1Phase 2Not yet recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in corneal neuropathy (CNP) comparing Low-dose naltrexone eye drops with Placebo eye drops (2 arms). Primary endpoint: Change in Ocular Surface Disease Index score. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
naltrexone
03
Conditions
corneal neuropathy (CNP)
Beyond the preview
Go deeper on IRCT20251016067651N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251016067651N1.